Molecular imaging of cancer: MR spectroscopy and beyond

被引:50
|
作者
Pinker, K. [1 ]
Stadlbauer, A. [3 ]
Bogner, W. [2 ]
Gruber, S. [2 ]
Helbich, T. H. [1 ,2 ]
机构
[1] Med Univ Vienna, Dept Radiol, Div Mol & Gender Imaging, A-1090 Vienna, Austria
[2] Med Univ Vienna, Dept Radiol, MR Ctr Excellence, A-1090 Vienna, Austria
[3] Univ Erlangen Nurnberg, Dept Neurosurg, Neuroctr, Erlangen, Germany
关键词
Molecular imaging; MR spectroscopy; Cancer; Sodium imaging; Diffusion-weighted imaging; Breast; Prostate; Brain; MAGNETIC-RESONANCE-SPECTROSCOPY; HUMAN BRAIN-TUMORS; INVASIVE CERVICAL-CANCER; HUMAN BREAST-LESIONS; TISSUE SODIUM CONCENTRATION; PROTON NMR-SPECTROSCOPY; SQUAMOUS-CELL CARCINOMA; DIFFUSION-WEIGHTED MRI; LOW-GRADE GLIOMAS; IN-VIVO;
D O I
10.1016/j.ejrad.2010.04.028
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Proton magnetic resonance spectroscopic imaging is a non-invasive diagnostic tool for the investigation of cancer metabolism. As an adjunct to morphologic and dynamic magnetic resonance imaging, it is routinely used for the staging, assessment of treatment response, and therapy monitoring in brain, breast, and prostate cancer. Recently, its application was extended to other cancerous diseases, such as malignant soft-tissue tumours, gastrointestinal and gynecological cancers, as well as nodal metastasis. In this review, we discuss the current and evolving clinical applications of proton magnetic resonance spectroscopic imaging. In addition, we will briefly discuss other evolving techniques, such as phosphorus magnetic resonance spectroscopic imaging, sodium imaging and diffusion-weighted imaging in cancer assessment. (C) 2010 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:566 / 577
页数:12
相关论文
共 50 条
  • [41] MR Imaging of the Coronary Vasculature Imaging the Lumen, Wall, and Beyond
    Lin, Kai
    Carr, James C.
    RADIOLOGIC CLINICS OF NORTH AMERICA, 2015, 53 (02) : 345 - +
  • [42] Adolescent case of Alexander disease: MR imaging and MR spectroscopy
    Takanashi, J
    Sugita, K
    Tanabe, Y
    Niimi, H
    PEDIATRIC NEUROLOGY, 1998, 18 (01) : 67 - 70
  • [43] Brain MR imaging and proton MR spectroscopy in cognitive impairment
    Weiss, U
    Bacher, R
    Vonbank, H
    Kemmler, G
    Lingg, A
    Marksteiner, J
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2002, 12 : S375 - S376
  • [44] Metachromatic leukodystrophy - Diffusion MR imaging and proton MR spectroscopy
    Sener, RN
    ACTA RADIOLOGICA, 2003, 44 (04) : 440 - 443
  • [45] Use of proton MR spectroscopy and MR imaging to assess obesity
    BaracNieto, M
    Gupta, RK
    JMRI-JOURNAL OF MAGNETIC RESONANCE IMAGING, 1996, 6 (01): : 235 - 238
  • [46] Lowe syndrome: Proton MR spectroscopy, and diffusion MR imaging
    Sener, RN
    JOURNAL OF NEURORADIOLOGY, 2004, 31 (03) : 238 - 240
  • [47] MR imaging and proton MR spectroscopy in adult Krabbe disease
    Farina, L
    Bizzi, A
    Finocchiaro, G
    Pareyson, D
    Sghirlanzoni, A
    Bertagnolio, B
    Savoiardo
    Naidu, S
    Singhal, BS
    Wenger, DA
    AMERICAN JOURNAL OF NEURORADIOLOGY, 2000, 21 (08) : 1478 - 1482
  • [48] Magnetic Resonance Spectroscopy in Metabolic and Molecular Imaging and Diagnosis of Cancer
    Glunde, Kristine
    Artemov, Dmitri
    Penet, Marie-France
    Jacobs, Michael A.
    Bhujwalla, Zaver M.
    CHEMICAL REVIEWS, 2010, 110 (05) : 3043 - 3059
  • [49] Role of magnetic resonance imaging (MRI), MR spectroscopy (MRS) and other imaging modalities in breast cancer
    Sharma, U
    Kumar, V
    Jagannathan, NR
    NATIONAL ACADEMY SCIENCE LETTERS-INDIA, 2004, 27 (11-12): : 373 - 385
  • [50] MR imaging, MR spectroscopy, and diffusion tensor imaging of sequential studies in neonates with encephalopathy
    Barkovich, AJ
    Miller, SP
    Bartha, A
    Newton, N
    Hamrick, SEG
    Mukherjee, P
    Glenn, OA
    Xu, D
    Partridge, JC
    Ferriero, DM
    Vigneron, DB
    AMERICAN JOURNAL OF NEURORADIOLOGY, 2006, 27 (03) : 533 - 547